Stocks eked out a winning week. Here are the names that are now overbought

The S&P 500 logged a 0.5% weekly gain as traders balanced an in-line core inflation read with Nvidia’s blockbuster earnings momentum in semiconductors. Nvidia’s revenue growth projections for fiscal 2028 lifted parts of the chip complex, driving some stocks into overbought RSI (>70) conditions, while Salesforce jumped ~22% on a beat-and-raise plus a new partnership with Anthropic that eased AI viability fears. Smucker also beat-and-raised, with net sales up 5% and adjusted EPS up 71% (including an 84-cent tariff-refund boost), though management flagged a mixed pricing picture.

Analysis

The tape is rewarding proof of monetization, not AI rhetoric. CRM’s move matters because it converts the enterprise software debate from abstract disruption to distribution advantage: incumbents with embedded workflows can add AI features faster than point-solution vendors can prove replacement value. The second-order loser is the broader lower-quality SaaS basket; if investors now demand evidence of AI-driven retention or upsell, names with slower net retention and weaker data moats could see multiple compression even if fundamentals stay stable.

NVDA’s guidance spillover is less about one stock and more about a revised capex path for the AI supply chain. The near-term beneficiaries are memory, networking, and foundry adjacencies, but the risk is that the market is extrapolating a multi-year revenue curve into a few quarters of demand pull-forward. If hyperscaler budgets pause or lead times normalize, the high-beta semis trade can unwind quickly; the immediate move is momentum, the 1-3 month catalyst is channel checks on enterprise and cloud spend, and the 6-18 month question is whether AI ROI turns into recurring software spend or just a hardware cycle.

Contrarian view: this looks more like a positioning squeeze than a new fundamental regime. Overbought software can keep squeezing, but unless CRM’s AI contribution shows up in cRPO, seat growth, or margin leverage next quarter, the stock may have front-run the narrative. For NVDA, the consensus is underpricing how much good news is already embedded; the setup favors continued leadership, but only if revisions keep outpacing estimate cuts across the rest of semis.

Key Decisions for Investors

• Buy CRM only on a 3-5% pullback from the post-earnings gap; thesis is that AI monetization is real for platform software, but near-term upside is likely to be choppy. Falsifier: next quarter fails to show reacceleration in cRPO or operating margin leverage.
• Pair long CRM / short IGV over the next 1-3 months to express dispersion between proven AI distribution and weaker SaaS models. Risk: broad software multiple expansion if the market decides all enterprise software gets an AI premium.
• Use NVDA call spreads, not outright chase, for the next 4-8 weeks. The stock can stay expensive, but the better risk/reward is limited upside participation with defined downside if hyperscaler capex commentary cools.
• Watch MU as the cleaner second-order beneficiary for a tactical long in semis; if memory pricing and channel checks confirm the demand impulse, MU should have more operating leverage than NVDA from the same thematic flow.
• Set an alert for any reversal in the overbought semis basket: if SOXX loses its post-earnings breakout on heavier volume, fade the AI spillover trade and reduce exposure to high-beta software/semis until the next earnings cycle.